Exploring the weak association between occult hepatitis B infection and non-B non-C hepatocellular carcinoma in Japan, with insights into virology, epidemiology, and clinical implications.
Discover how TACE treatment provides new hope for HIV-positive patients with hepatocellular carcinoma, with research showing similar survival outcomes to HIV-negative patients.
Exploring the scientific evidence for repurposing oseltamivir (Tamiflu) as a potential treatment for liver cancer through NEU1 inhibition and lipophagy induction.
Exploring the demographic patterns and risk factors for Hepatocellular Carcinoma in Pakistan through recent clinical research findings.